| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |